Sarabjit Singh
14Patents
2h-index
18Co-inventors
47Inventor score
Filing activity: Sep 3, 2007 → Mar 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8277843B2 | Programmable buoyant delivery technology | Human Necessities | 21 | Active |
| US9913853B2 | Stabilized liquid fosaprepitant formulations | Human Necessities | 5 | Active |
| US10098890B2 | Stable carfilzomib formulations | Human Necessities | 2 | Active |
| US10912734B2 | Depot formulation | Human Necessities | 1 | Active |
| US10307432B2 | Stabilized liquid fosaprepitant formulations | Human Necessities | 1 | Active |
| US10966982B2 | Stable pharmaceutical formulations of pemetrexed | Human Necessities | 1 | Active |
| US10493079B2 | Stable carfilzomib formulations | Human Necessities | 0 | Active |
| US11596597B2 | Depot formulation | Human Necessities | 0 | Active |
| US10500185B2 | Stabilized cabazitaxel formulations | Human Necessities | 0 | Active |
| US11931362B2 | Stable pharmaceutical formulations of pemetrexed | Human Necessities | 0 | Active |
| US12324811B2 | Intranasal formulation | Human Necessities | 0 | Active |
| US9402808B2 | Liquid oral composition of lanthanum salts | Human Necessities | 0 | Active |
| US10933047B2 | Stabilized cabazitaxel formulations | Human Necessities | 0 | Active |
| US10188626B2 | Stabilized cabazitaxel formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.